From: Prognostic significance of serum osteopontin levels in small cell lung cancer
Characteristics | Univariate | Multivariate | ||||
---|---|---|---|---|---|---|
HR | 95% CI | P | HR | 95% CI | P | |
Gender (Male vs. Female) | 3.563 | 0.496–25.582 | 0.206 | 2.264 | 0.382–13.404 | 0.368 |
Age (< 60 vs. ≥60) | 0.819 | 0.140–4.806 | 0.825 | 2.091 | 0.514–8.502 | 0.302 |
Disease stage (Limited vs. Extended) | 4.277 | 1.233–14.835 | 0.022 | 3.429 | 1.096–10.726 | 0.034 |
Lymph node metastasis (N0 vs. N1–3) | 0.585 | 0.157–2.182 | 0.424 | 2.358 | 0.606–9.181 | 0.216 |
PS (0–1 vs. 2–3) | 4.820 | 1.196–19.424 | 0.027 | 4.004 | 1.281–12.513 | 0.017 |
Smoking history (Ever vs. Never) | 1.719 | 0.551–5.365 | 0.351 | 0.649 | 0.218–1.933 | 0.438 |
Pre-OPN (Negative vs. Positive) | 2.662 | 0.908–7.807 | 0.075 | 0.305 | 0.091–1.106 | 0.053 |
After-OPN (Negative vs. Positive) | 4.936 | 1.793–13.586 | 0.002 | 6.114 | 1.661–22.510 | 0.006 |